West Pharmaceutical Services (WST) Current Leases (2019 - 2025)
Historic Current Leases for West Pharmaceutical Services (WST) over the last 7 years, with Q3 2025 value amounting to $21.4 million.
- West Pharmaceutical Services' Current Leases rose 753.77% to $21.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 753.77%. This contributed to the annual value of $17.9 million for FY2024, which is 112.99% up from last year.
- According to the latest figures from Q3 2025, West Pharmaceutical Services' Current Leases is $21.4 million, which was up 753.77% from $20.9 million recorded in Q2 2025.
- West Pharmaceutical Services' Current Leases' 5-year high stood at $21.8 million during Q1 2025, with a 5-year trough of $8.1 million in Q3 2021.
- For the 5-year period, West Pharmaceutical Services' Current Leases averaged around $15.4 million, with its median value being $16.2 million (2023).
- As far as peak fluctuations go, West Pharmaceutical Services' Current Leases plummeted by 1818.18% in 2021, and later surged by 7204.3% in 2022.
- Quarter analysis of 5 years shows West Pharmaceutical Services' Current Leases stood at $9.3 million in 2021, then surged by 72.04% to $16.0 million in 2022, then grew by 10.62% to $17.7 million in 2023, then increased by 1.13% to $17.9 million in 2024, then rose by 19.55% to $21.4 million in 2025.
- Its Current Leases was $21.4 million in Q3 2025, compared to $20.9 million in Q2 2025 and $21.8 million in Q1 2025.